PHVS
Pharvaris N.V. Ordinary Shares (PHVS)
$41
About Pharvaris N.V. Ordinary Shares (PHVS)
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Details
Daily high
$17.67
Daily low
$15.45
Price at open
$17.30
52 Week High
$33.00
52 Week Low
$15.37
Market cap
886.3M
Dividend yield
0.00%
Volume
213
Avg. volume
51,434
P/E ratio
-6.12
Pharvaris N.V. Ordinary Shares News
Details
Daily high
$17.67
Daily low
$15.45
Price at open
$17.30
52 Week High
$33.00
52 Week Low
$15.37
Market cap
886.3M
Dividend yield
0.00%
Volume
213
Avg. volume
51,434
P/E ratio
-6.12